February 20, 2024 01:18 PM ESTUpdated 01:30 PM
Pharma
Marketing

Mar­ket­ingRx roundup: Op­di­vo, Veozah on Peo­ple’s Choice Awards; AZ pub­lish­es new sus­tain­abil­i­ty re­port

Beth Snyder Bulik

Senior Editor

Astel­las and BMS brands on the red car­pet. The Peo­ple’s Choice Awards may not be quite as high-pro­file as the Os­cars or Em­mys, but it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times